Danna Dennis-Calder
Medical · Atlanta, GANPI 1811080914
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $71,275 of the $86,826 with a category attached, or 82.1%. AbbVie accounts for 94.8% of it on its own, with 29 other manufacturers making up the rest. Among medical clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 679 payments — averaging $127.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$82K
- Novartis$986
- Johnson & Johnson$453
- Dermavant Sciences, Inc.$315
- E.r. Squibb & Sons, L.L.C.$300
- Incyte Corporation$264
- plus $2K from 24 others
What the payments were for
- Consulting fees$3,5754%
- Speaking & faculty fees$71,27582%
- Travel & lodging$1,2961%
- Food & beverage$10,50212%
- Education$1780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 379 | $82,329 |
| Novartis | 74 | $986 |
| Johnson & Johnson | 22 | $453 |
| Dermavant Sciences, Inc. | 15 | $315 |
| E.r. Squibb & Sons, L.L.C. | 22 | $300 |
| Incyte Corporation | 13 | $264 |
| Regeneron Healthcare Solutions, Inc. | 13 | $243 |
| Sun Pharmaceutical Industries Inc. | 8 | $210 |
| Mayne Pharma Commercial LLC | 33 | $183 |
| Lilly USA, LLC | 10 | $179 |
| LEO Pharma Inc. | 31 | $174 |
| Pfizer | 9 | $174 |
| UCB, Inc. | 7 | $157 |
| Arcutis Biotherapeutics, Inc. | 5 | $103 |
| Revance Therapeutics, Inc. | 2 | $96 |
| Sanofi | 4 | $93 |
| Journey Medical Corporation | 4 | $74 |
| Almirall LLC | 3 | $67 |
| Botanix SB Inc | 4 | $63 |
| Biofrontera Inc. | 3 | $53 |
| Galderma Laboratories, L.p. | 3 | $46 |
| Amgen | 2 | $45 |
| Boehringer Ingelheim | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
| Organon | 4 | $33 |
| Organogenesis Inc. | 2 | $28 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| EPI Health, LLC | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$86,826 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dutasteride | 100 | $2,818 |
| Clobetasol Propionate | 23 | $1,120 |
| Ketoconazole | 39 | $335 |
| ValacyclovirValacyclovir Hcl | 11 | $248 |
| Triamcinolone Acetonide | 21 | $238 |
| Mupirocin | 18 | $164 |
Paid to pharmacies, not to this prescriber.
Other medical in Atlanta
- Kimberly OrleckAtlanta$727K
- Ferrina ShethAtlanta$49K
- Adriana RuizAtlanta$39K
- Punam PunjaAtlanta$31K
- Adrienne AndersonAtlanta$25K
- Jeremiah RobinsonAtlanta$23K
- Steven SchmittAtlanta$15K
- Taylor WeintraubAtlanta$15K
- Margaret SellersAtlanta$11K
- Katherine QuinleyAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.